Literature DB >> 27344410

The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.

Ross Mason1, Anil Kapoor2, Zhihui Liu3, Olli Saarela3, Simon Tanguay4, Michael Jewett5, Antonio Finelli5, Louis Lacombe6, Jun Kawakami7, Ronald Moore8, Christopher Morash9, Peter Black10, Ricardo A Rendon11.   

Abstract

INTRODUCTION AND
OBJECTIVE: Patients who undergo surgical management of renal cell carcinoma (RCC) are at risk for chronic kidney disease and its sequelae. This study describes the natural history of renal function after radical and partial nephrectomy and explores factors associated with postoperative decline in renal function.
METHODS: This is a multi-institutional cohort study of patients in the Canadian Kidney Cancer Information System who underwent partial or radical nephrectomy for RCC. Estimated glomerular filtration rate (eGFR) and stage of chronic kidney disease were determined preoperatively and at 3, 12, and 24 months postoperatively. Linear regression was used to determine the association between postoperative eGFR and type of surgery (radical vs. partial), duration of ischemia, ischemia type (warm vs. cold), and tumor size. RESULTS AND LIMITATIONS: With a median follow-up of 26 months, 1,379 patients were identified from the Canadian Kidney Cancer Information System database including 665 and 714 who underwent partial and radical nephrectomy, respectively. Patients undergoing radical nephrectomy had a lower eGFR (mean = 19ml/min/1.73m2 lower) at 3, 12, and 24 months postoperatively (P<0.001). Decline in renal function occurred early and remained stable throughout follow-up. A lower preoperative eGFR and increasing age were also associated with a lower postoperative eGFR (P<0.01). Ischemia type and duration were not predictive of postoperative decline in eGFR (P>0.05). Severe renal failure (eGFR<30ml/min/1.73m2) developed postoperatively in 12.5% and 4.1% of radical and partial nephrectomy patients, respectively (P<0.001).
CONCLUSIONS: After the initial postoperative decline, renal function remains stable in patients undergoing surgery for RCC. Patients undergoing radical nephrectomy have a greater long-term reduction in renal function compared with those undergoing partial nephrectomy. Ischemia duration and type are not predictive of postoperative renal function when adhering to generally short ischemia durations.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Partial nephrectomy; Radical nephrectomy; Renal cell carcinoma; Renal failure; Renal function

Mesh:

Year:  2016        PMID: 27344410     DOI: 10.1016/j.urolonc.2016.05.025

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Authors:  Wassim Kassouf; Leonardo L Monteiro; Darrel E Drachenberg; Adrian S Fairey; Antonio Finelli; Anil Kapoor; Jean-Baptiste Lattouf; Michael J Leveridge; Nicholas E Power; Frederic Pouliot; Ricardo A Rendon; Robert Sabbagh; Alan I So; Simon Tanguay; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-05-31       Impact factor: 1.862

2.  Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.

Authors:  Alice Dragomir; Armen Aprikian; Anil Kapoor; Antonio Finelli; Frédéric Pouliot; Ricardo Rendon; Peter C Black; Ronald Moore; Rodney H Breau; Jun Kawakami; Darrell Drachenberg; Jean-Baptiste Lattouf; Simon Tanguay
Journal:  CMAJ Open       Date:  2017-12-11

3.  Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery.

Authors:  Renato Corradi; Aashish Kabra; Melissa Suarez; Jacob Oppenheimer; Zhamshid Okhunov; Hugh White; Stephanie Nougaret; Hebert A Vargas; Jaime Landman; Jonathan Coleman; Michael A Liss
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

4.  What is the Optimal Management Strategy for Multifocal and Hereditary Kidney Cancer?

Authors:  Joseph A Baiocco; Adam R Metwalli
Journal:  J Ren Med       Date:  2017-04-01

Review 5.  Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients.

Authors:  Aleksandra Semeniuk-Wojtaś; Arkadiusz Lubas; Rafał Stec; Cezary Szczylik; Stanisław Niemczyk
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

Review 6.  Multiplex Partial Nephrectomy, Repeat Partial Nephrectomy, and Salvage Partial Nephrectomy Remain the Primary Treatment in Multifocal and Hereditary Kidney Cancer.

Authors:  Joseph A Baiocco; Adam R Metwalli
Journal:  Front Oncol       Date:  2017-10-20       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.